VIARTIS
|
||
|
PARKINSON'S DISEASE NEWS
|
|
25th August 2009 - New research THE COMPARISON OF L-DOPA AND
DOPAMINE AGONISTS Based on 29 clinical trials involving over 5000 people, dyskinesia, dystonia and motor fluctuations occurred less in people using dopamine agonists. However, various non-motor adverse effects were worse in those using dopamine agonists including : edema (fluid accumulation), somnolence (sleepiness), dizziness, hallucinations, constipation, and nausea. Some agonists are also known to cause compulsions. People treated with dopamine agonists were also significantly more likely than people taking L-dopa to discontinue treatment because of adverse events. The control of Parkinson's Disease symptoms was found to be better with the use of L-dopa than with dopamine agonists. For more current news go to Parkinson's Disease News.
E-MAIL NOTIFICATION : If you would like to be notified by e-mail when any new research, news reports, new books, or new resources are added to Parkinson's Disease News, please double click on E-MAIL NOTIFICATION, or e-mail [email protected]. No form of identity is required. E-mail addresses are not used for any other purpose. LOW RESOLUTION VERSION : There is a low resolution version of this page INTENDED FOR THOSE PEOPLE THAT EITHER : use 800x600 resolution on their monitors, or have eyesight difficulties, or have slow Internet speeds. GO TO LOW RESOLUTION VERSION Parkinson's Disease News details all significant new research, news reports, new books, and new resources concerning Parkinson's Disease and those medical disorders that often coincide with Parkinson's Disease. It is compiled from an analysis of all newly published research, news reports, new clinical trials, all newly published books, and new web sites. A summary and analysis of the new research are provided, as well as links to the complete abstracts and news reports.
|
||
|
||
©2006-2009 Viartis | ||
2015-11-10 13:47:24 | ||
[email protected] |